CoChat

In‐hospital cardiac arrest is associated with use of non‐antiarrhythmic QTc‐prolonging drugs

Open access
De Bruin, Marie L., Langendijk, Pim N. J., Koopmans, Richard P., Wilde, Arthur A. M., Leufkens, Hubert G. M., Hoes, Arno W. · 2007 · British Journal of Clinical Pharmacology
Cited by 113

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Aims: QTc interval‐prolonging drugs have been linked to cardiac arrhythmias, cardiac arrest and sudden death. In this study we aimed to quantify the risk of cardiac arrest associated with the use of non‐antiarrhythmic QTc‐prolonging drugs in an academic hospital setting. Methods: We performed a case–control study in which patients, for whom intervention of the advanced life support resuscitation team was requested for cardiac arrest between 1995 and 2003 in the Academic Medical Centre, Amsterdam, were compared with controls regarding current use of non‐antiarrhythmic QTc‐prolonging drugs. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using unconditional logistic regression, adjusting for potential confounding factors. Results: A statistically significant increased risk of cardiac arrest (OR 2.1, 95% CI 1.2, 3.5) was observed in patients who received QTc‐prolonging drugs (42/140). The risk was more pronounced in patients receiving doses > 1 defined daily dose (OR 2.5, 95% CI 1.1, 5.9), patients taking > 1 QTc‐prolonging drug simultaneously (OR 4.8, 95% CI 1.6, 14) and patients taking pharmacokinetic interacting drugs concomitantly (OR 4.0, 95% CI 1.2, 13). Conclusions: Use of non‐antiarrhythmic QTc‐prolonging drugs in hospitalized patients with several underlying disease is associated with an increased risk of cardiac arrest. The effect is dose related and pharmacokinetic drug–drug interactions increase the risk substantially. Physicians caring for inpatients should be made aware of the fact that these non‐antiarrhythmic drugs may be hazardous, so that potential risks can be weighed against treatment benefits and additional cardiac surveillance can be requested, if necessary.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.2006.02722.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 113

Metadata

Authors
De Bruin, M. L., Langendijk, P. N. J., Koopmans, R. P., Wilde, A. A. M., Leufkens, H. G. M., & Hoes, A. W.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2006-07-21
Volume
63
Issue
2
Pages
216-223
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W2172237983
Cited by
113
References
3
FWCI
1.97
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In‐hospital cardiac arrest is associated with use of non‐antiarrhythmic QTc‐prolonging drugs. https://app.cochat.ai/papers/10.1111/j.1365-2125.2006.02722.x
The paper
De Bruin, M. L., Langendijk, P. N. J., Koopmans, R. P., Wilde, A. A. M., Leufkens, H. G. M., & Hoes, A. W. (2007). In‐hospital cardiac arrest is associated with use of non‐antiarrhythmic QTc‐prolonging drugs. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2006.02722.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.